Compounds > n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine
Page last updated: 2024-08-16

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and cholecystokinin

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with cholecystokinin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bentley, MT; Webster, JM; Wojcikiewicz, RJ1

Other Studies

1 other study(ies) available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and cholecystokinin

ArticleYear
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits ligand binding to certain G protein-coupled receptors.
    European journal of pharmacology, 2003, Aug-01, Volume: 474, Issue:1

    Topics: Animals; Binding, Competitive; Cell Membrane; Cholecystokinin; Diprenorphine; Ethylenediamines; Humans; Ligands; N-Methylscopolamine; Rats; Receptors, G-Protein-Coupled; Tumor Cells, Cultured

2003